JIPOAd
ESID
TCR
  • Users Online: 169
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
   Table of Contents - Current issue
Coverpage
January-March 2020
Volume 3 | Issue 1
Page Nos. 1-47

Online since Friday, February 21, 2020

Accessed 4,568 times.

PDF access policy
Journal allows immediate open access to content in HTML + PDF
View as eBookView issue as eBook
Access StatisticsIssue statistics
RSS FeedRSS
Show all abstracts  Show selected abstracts  Export selected to  Add to my list
LETTER TO THE EDITOR  

Cancer immunotherapy for immunocompromised patients: An often ignored, yet vital puzzle p. 1
Jyoti Bajpai
DOI:10.4103/2666-2345.278414  
[HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta
REVIEW ARTICLES Top

Immune checkpoint blockade in gastrointestinal cancers: The current status and emerging paradigms p. 3
Mihailo Miljanic, Anna Capasso, Todd A Triplett, S Gail Eckhardt, Kyaw L Aung
DOI:10.4103/JIPO.JIPO_1_20  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

Bromodomain and extra-terminal (BET) domain protein inhibitors for solid tumor cancers p. 16
Martin V Nguyen, Lydia Loof, Gerald S Falchook
DOI:10.4103/JIPO.JIPO_2_20  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta
CASE REPORT Top

Ramucirumab and docetaxel in patients with metastatic urothelial carcinoma harboring fibroblast growth factor receptor alterations: A case series and literature review p. 23
Katherine Emilie Rhoades Smith, Emilie Elise Hitron, Greta A Russler, Deborah A Baumgarten, Mehmet Asim Bilen
DOI:10.4103/JIPO.JIPO_22_19  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

Pneumocystis infection in two patients treated with both immune checkpoint inhibitor and corticoids p. 27
Maroun Sadek, Angela Loizidou, Annie Drowart, Sigi Van den Wijngaert, Maria Gomez-Galdon, Sandrine Aspeslagh
DOI:10.4103/JIPO.JIPO_23_19  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

A case report of a cutaneous mucinous reaction associated with erlotinib therapy used in the treatment of metastatic tonsillar sinus squamous cell carcinoma p. 31
Benjamin D Freemyer, Carlos A Torres-Cabala, Anisha B Patel
DOI:10.4103/JIPO.JIPO_21_19  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta
GUIDELINE AND CONSENSUS Top

Highlights on the management of oligometastatic disease Highly accessed article p. 34
Salem M Alshehri, Khaled Alkattan, Ahmed Abdelwarith, Hussain Alhussain, Shaker Shaker, Majed Alghamdi, Hossam Alassaf, Ali Albargawi, Manal Al Naimi, Ameen Alomair, Saif Althaqfi, Adnan Alhebshi, Majid Alothman, AbdulRahman Jazieh
DOI:10.4103/JIPO.JIPO_24_19  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta
INDUSTRY NEWS Top

Introducing the 3rd Annual PARP and DNA Damage Response Inhibitors Summit p. 45

DOI:10.4103/2666-2345.277794  
[HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

IO360° speaker interview: Q and A with Dr. Crystal Mackall p. 46

DOI:10.4103/2666-2345.275505  
[HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

Finding T-Cure: A CEO's vision for the future of adoptive cell immunotherapy p. 47

DOI:10.4103/2666-2345.277828  
[HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

CALL FOR PAPERS
Special issue 2019